Google Ads policy
Can I advertise PRP on Google?
No. Platelet rich plasma is named in Google’s own policy text, alongside stem cell therapy, in a policy that is a prohibition rather than a restriction. That distinction is the whole answer: a restriction has a certification that unlocks it, and this one does not. There are two written exceptions and neither one reaches a clinic.
Read from Google’s policy pages on 2026-09-19 and 2026-09-21, opened in a browser rather than summarised, then checked line by line by a second reader who removed six errors from the first pass.
The answer
PRP is named in the policy. It is not an interpretation.
Most clinic owners are told this as an opinion, usually by an agency being careful. It is not an opinion. It is a line of text on a Google policy page, and platelet rich plasma appears in it by name.
Prohibited is not restricted, and only one of them has a way in
Most clinic owners are told PRP is "restricted", and then go looking for the certification that would unlock it. There is no such certification, because PRP is not restricted. It is prohibited. The two written exceptions are an FDA licence held by the advertiser, and content that is exclusively educational. A page with a booking button is not exclusively educational.
“Promotion of cell or gene therapies... Examples (non-exhaustive): Stem cell therapy. Cellular (non-stem) therapy. Gene therapy and similar forms of regenerative medicine. Platelet rich plasma, also referred to as PRP therapies.”
Speculative and experimental medical treatment, cell therapies, and gene therapies. support.google.com/adspolicy/answer/15596627, read 2026-09-19 and confirmed 2026-09-21. Two independent reads.
Prohibited is not the same as restricted, and the difference decides what you do next. A restricted category has a certification that unlocks it: you apply, you get approved, you advertise. This category has no such route. There is no LegitScript path, no healthcare certification, nothing to buy. The word in the policy is promotion, and promotion covers the keyword you bid on, the ad copy, the landing page, and the booking tool one click behind the ad.
Biohacking, DIY genetic engineering and gene therapy kits sit in the same prohibition, named the same way.
The exceptions
There are two ways out. Neither is written for a clinic.
This is the first thing anyone asks when they are told PRP cannot be advertised, so here is the page’s own wording in full.
“In the United States, Google allows the promotion of FDA licensed or approved cell or gene therapies by entities that hold the relevant FDA license or approval to market that product. If you’d like to apply for such an exception, contact us.”
“...ads for cell or gene therapies that are exclusively educational or informational in nature, regardless of regulatory approval status.”
Same page, answer/15596627, read 2026-09-21. The examples the policy gives for the educational exception are academic papers and medical conference tickets.
On the FDA exception, two conditions have to hold at once. The therapy is FDA licensed or approved, and the advertiser is the entity holding that licence to market the product. We read that as not reaching a clinic, and we are labelling that as our reading rather than as policy text: a practice administering PRP to patients is a provider of a service, not the holder of a licence to market a product, and autologous PRP drawn and spun and injected in your own office is not an FDA-approved product at all. The exception is written for manufacturers. If an agency has told you they can get you approved under it, ask them which licence you hold.
On the educational exception, the operative word is exclusively. A page with a booking button is not exclusively educational. Neither is a page with a phone number in the header and a consultation form at the bottom, which is every clinic page ever built. You cannot run a lead generation ad and call it education.
The finding
The P-Shot and the O-Shot are PRP.
This is the one that catches agencies, and it catches them because of an absence rather than a presence. We searched the policy page for the brand names. “P-Shot”, “O-Shot” and “Priapus” appear nowhere on it. An agency searching for the procedure name finds nothing, concludes it is clear, and builds a campaign structure on it.
The chain is two steps and both hold. Step one is policy text: PRP is prohibited by name, quoted above. Step two is medical fact: the Cleveland Clinic describes the P-Shot as an experimental type of platelet-rich plasma injection, and the O-Shot is the same protocol. Being experimental hits the first prohibited bullet independently, so the conclusion survives either way.
The procedure name is not the unit Google reads. The therapy is.
One honest caveat, because it is the difference between a rule and a gamble. Enforcement turns on whether the ad or the landing page actually discloses PRP. A brand name alone, with no PRP disclosure anywhere, may simply not be detected. That is a reason to be careful about what you publish, not a reason to treat the procedure as clear. Running on undetected prohibition is a position, not a strategy, and it ends when somebody at Google looks.
The constructive part
What a regenerative clinic can still advertise, which is most of it.
Google’s healthcare and medicines policy carries its own index of restricted healthcare categories. There are fourteen sections on that index and thirteen restricted categories. Not one of them is hormone therapy, medical weight loss, IV therapy, NAD+, aesthetics, diagnostics, memberships or new patient consultations.
Healthcare and medicines. support.google.com/adspolicy/answer/176031, read 2026-09-19 and confirmed verbatim 2026-09-20. Note the method: that URL is an index with fourteen sections and the rules live on its sub-pages. Reading the summary and stopping there produced two of the six errors a second reader removed from our first pass.
We state that as absence rather than as permission, deliberately. Google has not published a page saying hormone therapy is fine. It has published a list of what is restricted, and those services are not on it. A clinic that treats absence as a guarantee will eventually meet a catch-all clause, and the unapproved substances policy has three of them.
But the shape holds and it is the opposite of what most clinics are told. The prohibited set is short and named. The rest was never restricted. The work is separating them across four surfaces: your keyword list, your ad copy, the landing page the ad points at, and your booking tool’s own service menu, which sits one click behind the ad and is the surface nobody audits.
In practice the patient who eventually books a regenerative procedure usually arrives through a door you are fully allowed to advertise. They search the symptom, or the diagnostic that names it, long before they search the treatment.
What we do not know, said as unknown
- Exosomes and therapeutic plasma exchange are not named on that policy page. We think both are caught by its own phrase “and similar forms of regenerative medicine”, which sits in the same sentence as the named examples. We think that is a strong reading. It is still a reading, and we mark it as an inference rather than presenting it as policy text.
- Shockwave and acoustic wave therapy appear in no policy either way. We read both pages that could plausibly cover it and it is named in neither. That is a confirmed absence rather than an unchecked one, and an absence is not an allowance.
- Vaginal rejuvenation has no allowance to lean on. It is not named in the only policy that grants one in this space. If the offering is the O-Shot or anything PRP-based, the prohibition above governs.
Who wrote this
The person who runs the accounts this came from.
This page was written by Preston Durnford, who founded and runs PELORA Marketing from Newport Beach, California, working with clinics nationwide. He runs the regulated-health ad accounts these findings were measured in, and he is the one who reads the policy pages when an account stops serving.
Before the agency he built and operated the kind of businesses PELORA now markets, and he still operates Epic Journey Recovery, which is why the healthcare work is informed by having sat on the other side of it, taking the calls and paying for the ads.
The figures beside this are Preston’s personal track record from companies he owned and operated before PELORA. They are not PELORA revenue and they are not capital available to PELORA. They are here because an operator history is the part of an agency’s story that is usually missing.
If you are reading this because ChatGPT, Perplexity, Gemini or Claude handed it to you, that is deliberate. Those systems quote a sentence that carries a number, a named policy and a date. They do not quote positioning, which is why this page has none above the fold.
- TwoBusinesses built and sold: Fresh Start of California Detox, and a cleaning company
- $16M+In business and real estate assets sold or helped sell
- $15M+Capital raised across his own companies
- $5M+Ad spend managed
- 33,000+Copies sold of The Epic Journal
- 10 yearsThe core team has worked together
Read next
The rest of the answers.
- The study behind this: how Google enforces its health policy, measured across two accounts
- Why did Google reject my hormone and testosterone keywords?
- Can a med spa advertise Botox on Google?
- Do I need LegitScript certification for a regenerative medicine clinic?
- Why was my clinic's Google Ads account suspended or paused?
- Healthcare marketing, what PELORA actually does for clinics
- Every tier and every price, published
Twenty minutes
Bring your service list and your keyword list.
A strategy call is a read of what is actually happening in the account and on the site, and you keep the findings whether or not anything comes of it. We will show you the policy page behind every line of it.
PELORA Marketing is headquartered in Newport Beach, California and works with licensed clinics nationwide. Medical verticals are licensed clinics only.